Stereotaxis Inc (STXS) Stock Price, Quote & News

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is design...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 314 678 6100

Website: www.stereotaxis.com

Address:

710 North Tucker Boulevard, Suite 110, Saint Louis, United States

brunoq14 Mar. 15 at 12:35 PM

$STXS Is this stock capable of significant market cap expansion?

1 · Reply

S144 Mar. 13 at 9:44 PM

$STXS Stereotaxis said it expects double digit revenue growth for full year 2026, with annual revenue projected to surpass $40 million.

1 · Reply

1967jcb Mar. 13 at 9:38 PM

$STXS wait a minute…We like this?

0 · Reply

Eddypgil Mar. 12 at 3:25 PM

$STXS not giving up at $1.90. At what price would David sell?

0 · Reply

Eddypgil Mar. 12 at 2:56 PM

$STXS how much is the company worth to a company like Medtronic ? A company with sales channels to every hospital.

0 · Reply

jb06000 Mar. 11 at 9:53 PM

$STXS buying more to avarage down. ISRG is worth $182 billions we have a long way to go but we will get there.

1 · Reply

Eddypgil Mar. 11 at 6:40 PM

$STXS a good ceo and management team can fix the catheter manufacturing issues. Maybe APT can pick up slack

0 · Reply

cheating_stock_investor Mar. 11 at 4:48 PM

$STXS that brief spike after earnings looks like a few shorts who covered because david was being honest about underperforming and now the selling is all the longs who given up on this. The only thing that remains is the potential of making this happen and for most people they will be smarter to wait and see if he can make it happen before they assume it will happen. In a nutshell it is a gamble at this point and nobody can take credit for saying they were smart for buying at these levels when nobody not even david is certain he could pull this off. Interestingly enough both ceo's of $AFIB and $STXS were named david. This time it looks like golliath is beating them down.

0 · Reply

ihuntbiggame Mar. 11 at 3:05 PM

$STXS if you stay on this chat realize how many liars & cheats there are on these sites. Make your own decisons or at least find out who they are so you can meet them having lunch with thier families. TAKE EVERYTHING FROM THEM.

0 · Reply

Eddypgil Mar. 11 at 2:56 PM

$STXS with things falling into place and lack of execution I wouldn’t be surprised to see company bought out

0 · Reply

Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks

Mar 9, 2026, 8:17 PM EDT - 6 days ago

Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript

Mar 9, 2026, 4:01 PM EDT - 6 days ago

Stereotaxis Reports 2025 Full Year Financial Results

Feb 12, 2026, 9:00 AM EST - 4 weeks ago

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

Feb 9, 2026, 8:06 AM EST - 4 weeks ago

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

Jan 6, 2026, 8:01 AM EST - 2 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Nov 24, 2025, 8:58 AM EST - 3 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 11, 2025, 7:51 PM EST - 4 months ago

Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 4:01 PM EST - 4 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

Nov 10, 2025, 4:05 PM EST - 4 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Oct 21, 2025, 9:00 AM EDT - 5 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 15, 2025, 7:32 AM EDT - 5 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Oct 13, 2025, 7:34 AM EDT - 5 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Sep 22, 2025, 7:56 AM EDT - 6 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

Sep 2, 2025, 8:08 AM EDT - 6 months ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 7:51 AM EDT - 6 months ago

Stereotaxis to Present at Upcoming Investor Conferences

Aug 28, 2025, 7:47 AM EDT - 7 months ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 8, 2025, 1:24 PM EDT - 7 months ago

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:01 PM EDT - 7 months ago

Stereotaxis Reports 2025 Second Quarter Financial Results

Jul 28, 2025, 7:48 AM EDT - 8 months ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 23, 2025, 8:00 AM EDT - 8 months ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 17, 2025, 8:32 AM EDT - 8 months ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 6, 2025, 2:13 AM EDT - 9 months ago

Stereotaxis: Recurring Revenue Inflection

Jul 1, 2025, 9:00 AM EDT - 9 months ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

May 12, 2025, 7:04 PM EDT - 10 months ago

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 4:01 PM EDT - 10 months ago

Stereotaxis Reports 2025 First Quarter Financial Results

Apr 22, 2025, 7:00 AM EDT - 11 months ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 21, 2025, 8:00 AM EDT - 11 months ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 10, 2025, 8:02 AM EDT - 1 year ago

Stereotaxis to Present at 37th Annual Roth Conference

Mar 7, 2025, 9:10 AM EST - 1 year ago

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Mar 3, 2025, 10:34 AM EST - 1 year ago

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:32 AM EST - 1 year ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:31 AM EST - 1 year ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:30 AM EST - 1 year ago

Stereotaxis Reports 2024 Full Year Financial Results

Feb 25, 2025, 8:03 AM EST - 1 year ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 14, 2025, 10:41 AM EST - 1 year ago

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Feb 3, 2025, 4:05 PM EST - 1 year ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order

Jan 27, 2025, 8:00 AM EST - 1 year ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 14, 2025, 7:21 AM EST - 1 year ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Dec 9, 2024, 7:25 AM EST - 1 year ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 2, 2024, 8:45 AM EST - 1 year ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Dec 2, 2024, 5:03 AM EST - 1 year ago

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Nov 26, 2024, 8:28 AM EST - 1 year ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 11, 2024, 7:03 PM EST - 1 year ago

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

brunoq14 Mar. 15 at 12:35 PM

$STXS Is this stock capable of significant market cap expansion?

1 · Reply

S144 Mar. 13 at 9:44 PM

$STXS Stereotaxis said it expects double digit revenue growth for full year 2026, with annual revenue projected to surpass $40 million.

1 · Reply

1967jcb Mar. 13 at 9:38 PM

$STXS wait a minute…We like this?

0 · Reply

Eddypgil Mar. 12 at 3:25 PM

$STXS not giving up at $1.90. At what price would David sell?

0 · Reply

Eddypgil Mar. 12 at 2:56 PM

$STXS how much is the company worth to a company like Medtronic ? A company with sales channels to every hospital.

0 · Reply

jb06000 Mar. 11 at 9:53 PM

$STXS buying more to avarage down. ISRG is worth $182 billions we have a long way to go but we will get there.

1 · Reply

Eddypgil Mar. 11 at 6:40 PM

$STXS a good ceo and management team can fix the catheter manufacturing issues. Maybe APT can pick up slack

0 · Reply

cheating_stock_investor Mar. 11 at 4:48 PM

0 · Reply

ihuntbiggame Mar. 11 at 3:05 PM

0 · Reply

Eddypgil Mar. 11 at 2:56 PM

$STXS with things falling into place and lack of execution I wouldn’t be surprised to see company bought out

0 · Reply

jacksonjohn750 Mar. 11 at 2:26 PM

$STXS predictable. Looking around 1.5

0 · Reply

ihuntbiggame Mar. 11 at 2:25 PM

$STXS They are stealing your shares. $1.70 to $1 is a pretty nice gift. YW for the share, perhaps some of you BULLS need to a better job..

0 · Reply

ihuntbiggame Mar. 11 at 2:24 PM

$STXS They are stealing your shares basically or giving you a chance to add $1.70 bring it.

0 · Reply

ihuntbiggame Mar. 11 at 2:23 PM

$STXS They are stealing your shares if you are selling instead of adding.

0 · Reply

TonySoprano1987 Mar. 11 at 1:46 PM

$STXS sub $1 possible? Where is support?

1 · Reply

robh Mar. 11 at 1:06 PM

$STXS ever wonder why you see a stock like $STXS reporting rev of 8-9mil and /<.06) with nice increased and forward look trading at $2.X and then there are biotechs with no rev/no eps and years out from such trading at $50-$100 and even something like KDK: 1.1mil rev/<.48> trading at $8-9. Always found it fascinating

2 · Reply

RemitTekram Mar. 10 at 7:28 PM

$STXS Very bearish candles lately. Still waiting to get back in. It's been bouncing off $1.98 repeatedly over the last month, but isn't looking like it will remain as support.

2 · Reply

trigger_finger Mar. 10 at 7:25 PM

$STXS

1 · Reply

trigger_finger Mar. 10 at 6:41 PM

$STXS I can't get over the 500 catheters. I mean what in the actual f is that? Just some simple napkin math, 5 new Genesis X systems would consume 100 a month assuming 5 procedures a week on some very established EPs. David has been talking for last 18 months, and even in the last quarter about doing a big launch with Genesis X, "worse case scenario at EHRA or HRS" Not only can they not do that, they will be lucky to do that next year. They aren't even close to being able to making Genesis X at scale at any capacity and then the freaking catheter issue. The other board accused me of tanking the stock price by bringing up the need for funding and calling David's incompetence out. lmao. Low IQ folks want everything positively spun. I don't enjoy arguing w/ people that are disputing facts. This is quite possibly one of the most disastrous reports I have ever seen from an execution standpoint. I don't want to spend another second on this until next update. GL.

5 · Reply

Eddypgil Mar. 10 at 5:20 PM

$STXS CEOs family owns 15% of company. CEOs job is safe

1 · Reply

_Not_Sure_ Mar. 10 at 3:08 PM

$STXS earnings report was a nothing burger. So, why are we going up today?

3 · Reply

TonySoprano1987 Mar. 10 at 2:56 PM

$STXS the market likes the numbers and words... im not so bullish anymore and be happy with $3 EOY

0 · Reply

Market Cap	176.38M
Revenue (ttm)	26.92M
Net Income (ttm)	-24.05M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-89.34%
Debt to Equity Ratio	0.00

Volume	425,000
Avg Vol	542,848
Day's Range	N/A - N/A
Shares Out	93.33M
Stochastic %K	8%
Beta	1.38
Analysts	Strong Sell
Price Target	$4.20